Insmed (INSM) Net Margin (QoQ) (2011 - 2026)

Insmed (INSM) Net Margin (QoQ) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Insmed 23.26 Bn 22.03 Bn 258.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7,104.00
Dec 31, 2025 13,545.00
Sep 30, 2025 3,953.00
Jun 30, 2025 -2,306.00
Mar 31, 2025 -5,089.00
Dec 31, 2024 1,051.00
Sep 30, 2024 9,671.00
Jun 30, 2024 -12,469.00
Mar 31, 2024 1,425.00
Dec 31, 2023 -2,132.00
Sep 30, 2023 11,599.00
Jun 30, 2023 -7,201.00
Mar 31, 2023 2,504.00
Dec 31, 2022 -7,639.00
Sep 30, 2022 -4,698.00
Jun 30, 2022 3,152.00
Mar 31, 2022 2,313.00
Dec 31, 2021 3,976.00
Sep 30, 2021 1,755.00
Jun 30, 2021 -3,073.00